(Q33204006)

23 July 2017

title

Lack of efficacy of Doxil in TNF-alpha-based isolated limb perfusion in sarcoma-bearing rats (English)

1 reference

23 July 2017

1 reference

T L M ten Hagen

1

1 reference

23 July 2017

S Hoving

2

1 reference

23 July 2017

G Ambagtsheer

3

1 reference

23 July 2017

S T van Tiel

4

1 reference

23 July 2017

A M M Eggermont

5

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

British Journal of Cancer

23 July 2017

published in

1 reference

23 July 2017

volume

90

1 reference

23 July 2017

issue

9

1 reference

23 July 2017

page(s)

1830-1832

1 reference

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

23 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409755

Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409755

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409755

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409755

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409755

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409755

Convection and diffusion measurements using fluorescence recovery after photobleaching and video image analysis: in vitro calibration and assessment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409755

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409755

Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice

21 June 2018

1 reference

12 December 2020

Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study

1 reference

12 December 2020

Adriamycin in hyperthermic perfusion for advanced limb sarcomas

1 reference

12 December 2020

Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model

1 reference

12 December 2020

Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601688

1 reference

Dimensions Publication ID

23 July 2017

0 references

1 reference

23 July 2017

1 reference